Cite
HARVARD Citation
Keystone, E. et al. (n.d.). THU0609 Patient-Reported Outcomes from A Phase 3 Study of Baricitinib versus Placebo or Adalimumab in Patients with Active Rheumatoid Arthritis and An Inadequate Response To Background Methotrexate Therapy. Annals of the rheumatic diseases. pp. 412-413. [Online].